Study Backs BlueGnome CGH Arrays as Screening Tool to Improve IVF Success Rates | GenomeWeb

Using arrays to screen embryos during an in vitro fertilization cycle can improve pregnancy rates, according to a new study.

Pacific Reproductive Center, a Torrance, Calif.-based IVF clinic, blindly randomized 103 IVF cycles. In a treatment group of 55 cycles, the center used BlueGnome 24sure comparative genomic hybridization arrays to screen day-5 biopsies for aneuploid chromosomes prior to implantation of a single euploid embryo, while in a control group of 48 cycles, single embryos were selected using existing morphological scorecard approaches.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.